ImmunoGen, Inc. Debt to Equity Ratio 2010-2023 | IMGN
Current and historical debt to equity ratio values for ImmunoGen, Inc. (IMGN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. ImmunoGen, Inc. debt/equity for the three months ending September 30, 2023 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-09-30 | $0.26B | $0.56B | 0.46 |
| 2023-06-30 | $0.22B | $0.49B | 0.46 |
| 2023-03-31 | $0.17B | $0.12B | 1.37 |
| 2022-12-31 | $0.19B | $0.16B | 1.24 |
| 2022-09-30 | $0.18B | $0.18B | 1.02 |
| 2022-06-30 | $0.17B | $0.25B | 0.69 |
| 2022-03-31 | $0.18B | $0.31B | 0.57 |
| 2021-12-31 | $0.20B | $0.33B | 0.62 |
| 2021-09-30 | $0.22B | $0.08B | 2.85 |
| 2021-06-30 | $0.23B | $0.07B | 3.40 |
| 2021-03-31 | $0.25B | $0.09B | 2.68 |
| 2020-12-31 | $0.27B | $0.09B | 2.96 |
| 2020-09-30 | $0.29B | $-0.04B | -6.78 |
| 2020-06-30 | $0.29B | $-0.03B | -12.00 |
| 2020-03-31 | $0.30B | $-0.00B | -73.83 |
| 2019-12-31 | $0.31B | $-0.08B | -4.09 |
| 2019-09-30 | $0.34B | $-0.09B | -3.95 |
| 2019-06-30 | $0.36B | $-0.07B | -5.22 |
| 2019-03-31 | $0.35B | $-0.03B | -12.74 |
| 2018-12-31 | $0.28B | $0.01B | 25.92 |
| 2018-09-30 | $0.29B | $0.05B | 6.25 |
| 2018-06-30 | $0.29B | $0.09B | 3.27 |
| 2018-03-31 | $0.30B | $-0.04B | -8.30 |
| 2017-12-31 | $0.31B | $-0.02B | -17.47 |
| 2017-09-30 | $0.34B | $-0.11B | -3.03 |
| 2017-06-30 | $0.36B | $-0.17B | -2.05 |
| 2017-03-31 | $0.33B | $-0.17B | -1.98 |
| 2016-12-31 | $0.35B | $-0.15B | -2.30 |
| 2016-09-30 | $0.35B | $-0.12B | -2.89 |
| 2016-06-30 | $0.36B | $-0.08B | -4.39 |
| 2016-03-31 | $0.26B | $-0.04B | -6.40 |
| 2015-12-31 | $0.27B | $-0.02B | -16.08 |
| 2015-09-30 | $0.27B | $0.01B | 23.60 |
| 2015-06-30 | $0.28B | $0.04B | 7.94 |
| 2015-03-31 | $0.07B | $0.06B | 1.24 |
| 2014-12-31 | $0.05B | $0.08B | 0.66 |
| 2014-09-30 | $0.08B | $0.06B | 1.43 |
| 2014-06-30 | $0.09B | $0.08B | 1.18 |
| 2014-03-31 | $0.09B | $0.10B | 0.91 |
| 2013-12-31 | $0.07B | $0.13B | 0.56 |
| 2013-09-30 | $0.08B | $0.12B | 0.68 |
| 2013-06-30 | $0.09B | $0.12B | 0.75 |
| 2013-03-31 | $0.09B | $0.14B | 0.65 |
| 2012-12-31 | $0.10B | $0.14B | 0.70 |
| 2012-09-30 | $0.10B | $0.16B | 0.61 |
| 2012-06-30 | $0.10B | $0.08B | 1.15 |
| 2012-03-31 | $0.10B | $0.10B | 0.95 |
| 2011-12-31 | $0.09B | $0.12B | 0.81 |
| 2011-09-30 | $0.08B | $0.12B | 0.61 |
| 2011-06-30 | $0.08B | $0.14B | 0.56 |
| 2011-03-31 | $0.08B | $0.07B | 1.20 |
| 2010-12-31 | $0.08B | $0.08B | 0.97 |
| 2010-09-30 | $0.03B | $0.09B | 0.33 |
| 2010-06-30 | $0.04B | $0.10B | 0.35 |
| 2010-03-31 | $0.03B | $0.04B | 0.93 |
| 2009-12-31 | $0.03B | $0.05B | 0.74 |
| 2009-09-30 | $0.03B | $0.06B | 0.58 |
| 2009-06-30 | $0.03B | $0.07B | 0.51 |
| 2009-03-31 | $0.04B | $0.04B | 0.94 |
